May Wang
Corporate Officer/Principal bij HUTCHMED (CHINA) LIMITED
Profiel
Qing Mei Wang is currently working as the SVP-Business Development & Strategic Alliances at HUTCHMED (China) Ltd.
since 2010 and at Hutchison MediPharma Ltd.
since 2012.
Previously, Dr. Wang worked as the Head-Asia Discovery Biology at Eli Lilly & Co. Dr. Wang holds a doctorate degree from Purdue University.
Actieve functies van May Wang
| Bedrijven | Functie | Begin |
|---|---|---|
| HUTCHMED (CHINA) LIMITED | Corporate Officer/Principal | 01-01-2010 |
Hutchison MediPharma Ltd.
 Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Corporate Officer/Principal | 27-07-2011 |
Eerdere bekende functies van May Wang
| Bedrijven | Functie | Einde |
|---|---|---|
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
Opleiding van May Wang
| Purdue University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| HUTCHMED (CHINA) LIMITED | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Hutchison MediPharma Ltd.
Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Health Technology |
